Weed BUDZ
OTC BUDZ
$0.03 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM UTC

Weed (BUDZ) Accumulated Expenses (2010 - 2026)

Weed (BUDZ) posted quarterly Accumulated Expenses of $42326.0 for Q1 2026, down 82.2% year-over-year from $237750.0 in Q1 2025, and down 61.97% quarter-over-quarter from $111300.0 in Q4 2025.

Weed (BUDZ) Accumulated Expenses (2010 - 2026) Analysis & Trends

Weed's Accumulated Expenses history runs 13 years deep, the most recent figure standing at $42326.0 for Q1 2026.

  • In Q1 2026, Accumulated Expenses fell 82.2% year-over-year to $42326.0; the TTM figure through Mar 2026 stood at $42326.0 (down 82.2% YoY), while the FY2025 annual figure was $111300.0, up 31.1% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $42326.0, down from $111300.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $430342.0 in Q2 2023, with the low at $13000.0 in Q4 2023.
  • The 5-year median for Accumulated Expenses is $98100.0 (2025), against an average of $149581.9.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Expenses slumped 92.03% in 2022, then jumped 1628.28% in 2023.
  • Weed's Accumulated Expenses stood at $42266.0 in 2022, then plunged by 69.24% to $13000.0 in 2023, then jumped by 553.08% to $84900.0 in 2024, then soared by 31.1% to $111300.0 in 2025, then slumped by 61.97% to $42326.0 in 2026.
  • Business Quant data shows BUDZ's Accumulated Expenses at $42326.0 in Q1 2026, $111300.0 in Q4 2025, and $27500.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Weed 2.88 Mn 2.88 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 42,326.00
Dec 31, 2025 111,300.00
Sep 30, 2025 27,500.00
Jun 30, 2025 98,100.00
Mar 31, 2025 237,750.00
Dec 31, 2024 84,900.00
Sep 30, 2024 88,149.00
Jun 30, 2024 139,500.00
Mar 31, 2024 128,879.00
Dec 31, 2023 13,000.00
Sep 30, 2023 213,500.00
Jun 30, 2023 430,342.00
Mar 31, 2023 45,481.00
Dec 31, 2022 42,266.00
Sep 30, 2022 425,750.00
Jun 30, 2022 24,900.00
Mar 31, 2022 389,250.00
Dec 31, 2021 16,500.00
Sep 30, 2021 329,750.00
Jun 30, 2021 312,250.00